912 related articles for article (PubMed ID: 12193567)
1. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
Hui H; Yu R; Bousquet C; Perfetti R
Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
[TBL] [Abstract][Full Text] [Related]
2. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
Islam MS; Rahman SA; Mirzaei Z; Islam KB
Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs.
D'Amico E; Hui H; Khoury N; Di Mario U; Perfetti R
J Mol Endocrinol; 2005 Apr; 34(2):377-90. PubMed ID: 15821104
[TBL] [Abstract][Full Text] [Related]
4. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
Abraham EJ; Leech CA; Lin JC; Zulewski H; Habener JF
Endocrinology; 2002 Aug; 143(8):3152-61. PubMed ID: 12130581
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
Ahrén B
Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
[TBL] [Abstract][Full Text] [Related]
6. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription.
Hill ME; Asa SL; Drucker DJ
Mol Endocrinol; 1999 Sep; 13(9):1474-86. PubMed ID: 10478839
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Chepurny OG; Holz GG
Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
Hay CW; Sinclair EM; Bermano G; Durward E; Tadayyon M; Docherty K
J Endocrinol; 2005 Aug; 186(2):353-65. PubMed ID: 16079261
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 increases glucose-dependent activity of the homeoprotein IDX-1 transactivating domain in pancreatic beta-cells.
Hussain MA; Habener JF
Biochem Biophys Res Commun; 2000 Aug; 274(3):616-9. PubMed ID: 10924326
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids.
Abrahamsen N; Nishimura E
Endocrinology; 1995 Apr; 136(4):1572-8. PubMed ID: 7534705
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells.
Hui H; Wright C; Perfetti R
Diabetes; 2001 Apr; 50(4):785-96. PubMed ID: 11289043
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1.
Doyle ME; Egan JM
Recent Prog Horm Res; 2001; 56():377-99. PubMed ID: 11237222
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
[TBL] [Abstract][Full Text] [Related]
14. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
15. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
[TBL] [Abstract][Full Text] [Related]
16. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
Buteau J; Roduit R; Susini S; Prentki M
Diabetologia; 1999 Jul; 42(7):856-64. PubMed ID: 10440129
[TBL] [Abstract][Full Text] [Related]
18. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
Gefel D; Barg Y; Zimlichman R
Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
Fehmann HC; Göke R; Göke B
Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]